DDW Highlights: 10 October 2022

<p>Innovative. Evolving. Developing. Busy. These are just some of the words that come to mindwhen talking about not just the drug discovery sector, but the lives of those working in andaround it. Tune in every Monday for a roundup of industry highlights and updates, narrated by Multimedia Editor Megan Thomas.</p> <p>This round-up by DDW Digital Content Editor Diana Spencer spotlights new trial results and regulatory approvals shedding light and bringing hope into therapy areas of unmet need. The University of Birmingham and King’s College London have furthered our understanding of difficult to treat cancers, while Janssen has revealed encouraging results in gene therapies for X-linked retinitis pigmentosa. We have also seen the power of social media to make a difference in the FDA approval of a new treatment for ALS and a new hope for patients with mild Alzheimer’s disease.</p>